生物标志物 生物标志物
Yulaimy Batista Lozada1, Iria García de la Rosa1, Daniel Gutiérrez Luis1
1Center of ImmunoAssay, Havana, Havana, Cuba.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
一种新的APOE基因型测定试验可以准确地识别阿尔茨海默病风险等位基因. 这种简单,负担得起的方法通过确定个体基因型来帮助诊断和管理神经退行性疾病.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 生物化学 生物化学
背景情况:
- 脂蛋白E (ApoE) 对于脂质新陈代谢,葡萄糖和胆固醇平衡至关重要.
- APOE基因多态性定义了六种影响代谢功能的基因型.
- APOE基因定型识别了对晚发性阿尔茨海默病 (AD) 的易感性,特别是APOE ε4等位基因.
研究的目的:
- 开发和验证一种用于Apolipoprotein E (APOE) 基因定型的新,简单和负担得起的测定方法.
- 评估该试验在识别有神经退行性疾病风险的个体,特别是晚发性阿尔茨海默病中的有用性.
- 在古巴一群患有神经退行性疾病的人群中调查APOE等位基频率.
主要方法:
- 使用Chelex-100.00从干燥的血液斑点中提取基因组DNA.
- 开发针对APOE等位基 (ε2, ε3, ε4) 的等位基特异性原始体和内部对照.
- 多重实时PCR与高分辨率化分析 (HRMA) 结合用于APOE基因定型.
主要成果:
- 新的SUMASIGNAL APOE测试表明与商业套件100%一致.
- 实现了低的测试内和测试间变化系数 (<0.46%).
- 该方法可以检测到低至5 ng/μL的DNA度.
结论:
- 在SUMASIGNAL APOE测定是特定的,简单的,和成本效益的APOE基因型.
- 这种经过验证的测定方法有助于对阿尔茨海默病等疾病的风险评估和诊断.
- 在古巴开展了一项关于神经退行性疾病人群中APOE等位基频率的开创性研究.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516